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Abstract
People	who	use	alcohol	and	other	drugs(hereafter	“substances”)	and	who	are	over	
the	age	of	40	are	now	more	 likely	 to	die	of	a	non‐drug	related	cause	than	people	
who	use	substances	under	the	age	of	40.	This	population	will	therefore	potentially	
need	greater	access	to	palliative	and	end	of	life	care	services.	Initially,	the	purpose	
of	this	rapid	evidence	assessment	(REA),	conducted	August	2016–August	2017,	was	
to	explore	the	peer‐reviewed	evidence	base	in	relation	to	end	of	life	care	for	people	
with	problematic	substance	use.	The	following	databases	were	searched	using	date	
parameters	of	1	January	2004–1	August	2016:	Amed,	Psycharticles,	Ovid,	Ageinfo,	
Medline,	Ebscohost,	ASSIA,	Social	Care	Online,	Web	of	Knowledge,	Web	of	Science,	
SSCI,	Samsha,	NIAAA.	Data	were	extracted	using	a	predefined	protocol	incorporat‐
ing	inclusion	and	exclusion	criteria.	Given	the	dearth	of	evidence	emerging	on	inter‐
ventions	and	practice	responses	to	problematic	substance	use,	the	inclusion	criteria	
were	 broadened	 to	 include	 any	 peer‐reviewed	 literature	 focussing	 on	 substance	
use	specifically	and	end	of	 life	care.	There	were	60	papers	 that	met	 the	 inclusion	
criteria.	These	were	quality	assessed.	Using	a	textual	thematic	approach	to	catego‐
rise	findings,	papers	fell	into	three	broad	groups	(a)	pain	management,	(b)	homeless	
and	marginalised	 groups,	 and	 (c)	 alcohol‐related	 papers.	 In	 general,	 this	 small	 and	
diverse	literature	lacked	depth	and	quality.	The	papers	suggest	there	are	challenges	
for	health	and	social	care	professionals	 in	meeting	the	end	of	 life	needs	of	people	
who	use	 substances.	Addressing	 issues	 like	 safe	prescribing	 for	pain	management	
becomes	more	challenging	in	the	presence	of	substance	use	and	requires	flexible	ser‐
vice	provision	from	both	alcohol/drug	services	and	end	of	life	care	providers.	Work	
is	needed	to	develop	models	of	good	practice	in	working	with	co‐existing	substance	
use	and	end	of	life	conditions	as	well	as	prevalence	studies	to	provide	a	wider	context	
for	policy	development.
K E Y W O R D S
addiction,	alcohol,	drugs,	end	of	life	care,	palliative	care,	Rapid	Evidence	Assessment
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1  | BACKGROUND
In	 the	 last	 20	 years	 there	 have	 been	 numerous	 changes	 evident	
among	 the	 population	who	 use	 substances	 whether	 this	 be	 alco‐
hol	 or	 other	 drugs.	 The	most	 important	 changes	 appear	 to	 be	 an	
increase	 in	 the	 number	 of	 older	 drugs	 users,	 a	 subsequent	 rise	 in	
rates	 of	 death	 from	 non‐drug	 related	 conditions	 (Beynon,	 2010),	
an	increase	in	alcohol‐related	morbidity	among	older	users	(Kaplan	
et	al.,	2012)	and	 the	burgeoning	of	New	Psychoactive	Substances	
(NPS)	 use.	 The	 increase	 in	 older	 drug	 users	 may	 be	 associated	
with	 changes	 to	 the	 treatment	management	 for	 illicit	 opiate	users	
in	 the	1990’s	 (McKeganey,	2006)	 and,	 in	particular,	 the	expansion	
and	greater	availability	of	methadone	prescription	 (Clausen,	2008;	
Clausen,	Waal,	Thoresen,	&	Gossop,	2009).	This	increased	availabil‐
ity	means	that	increasing	numbers	of	people	with	current	and	previ‐
ous	substance	use	have	better	survival	rates	and	are	more	likely	to	
die	from	the	same	chronic	conditions	that	affect	the	general	popu‐
lation	(Corkery,	2008;	Beynon	et	al.,	2010).	It	may	be	that	some	of	
this	population	are	using	substances	for	longer	or	commencing	drug	
use	later	in	life	but,	whatever	the	cause,	there	has	been	an	increase	
in	 older	 drug	 users	 accessing	 drug	 treatment	 services	 in	 the	 UK	
(Beynon,	2010;	Beynon	et	al.,	2010).
Before	methadone	treatment	programmes	were	introduced,	peo‐
ple	who	used	substances	had	a	greater	risk	of	dying	from	overdoses	
(deliberate	or	accidental),	as	well	as	accidents,	violence	and	disease.	
These	could	be	related	to	the	substance	itself	or	its	route	of	admin‐
istration,	such	as	liver	disease,	HIV	(Human	Immunodeficiency	Virus)	
and	 bacterial	 infections	 (Gibson	 et	 al.,	 2008).	The	 adoption	 of	 evi‐
dence‐based	interventions	like	supervised	injecting	facilities,	needle	
exchange	programmes	and	outreach	programmes	for	illicit	drug	users	
is	considered	to	be	an	effective	overarching	policy	approach	for	re‐
ducing	harm	(Ritter	&	Cameron,	2006).	Harm	reduction	policies	and	
related	treatment	approaches	have	led	to	older	substance	users	(over	
the	 age	 of	 40)	 now	being	more	 likely	 to	 die	 of	 a	 non‐drug	 related	
cause	than	people	using	substances	under	the	age	of	40	(Benyon	et	
al.,	2010;	Stenbacka	et	al.,	2008).	However,	people	using	substances	
are	still	more	likely	to	die	at	an	earlier	age	than	the	general	population	
and	have	patterns	of	disease	and	morbidity	 that	 reflect	 the	 impact	
of	 substance	use	or	 the	 traumatic	 life	experiences	more	 frequently	
encountered	 in	 this	 group	 (Beynon,	Roe,	Duffy,	&	Pickering,	 2009;	
Beynon	et	al.,	2010).	 In	addition,	 there	are	higher	 rates	of	alcohol‐
related	morbidity	 and	mortality	 associated	with	 chronic	 and	 acute	
alcohol	 problems	 (Chang,	 Kreis,	Wong,	 Simpson,	 &	 Guymer,	 2008;	
Shield,	 Parry,	 &	 Rehm,	 2014;	Taylor	 et	 al.,	 2010).	 This	 highlights	 a	
more	nuanced	picture	of	 alcohol‐related	harm	given	 that	 the	high‐
est	 consumption	 is	 among	more	 affluent	 groups	 of	 the	 population	
(Office	for	National	Statistics,	2017)	but	the	highest	rates	of	alcohol‐
related	problems	are	among	the	least	affluent	(Erskine,	Maheswaran,	
Pearson,	&	Gleeson,	2010).
The	final	set	of	changes	is	the	increase	in	the	use	of	NPS.	Some	
of	the	more	immediate	consequences	of	NPS	use	are	evident	in	the	
prisons	 system	 and	 in	 admissions	 to	 hospital	 accident	 and	 emer‐
gency	departments	for	acute	intoxication	(Liakoni,	Dolder,	Rentsch,	
&	Liechti,	 2016;	Ralphs,	Williams,	Ashew,	&	Norton,	2017).	 These	
harmful	consequences	are	particularly	associated	with	people	who	
are	 homeless	 (Henshall	 et	 al.,	 2018).	 The	 impact	 of	 NPS	 use	 on	
mortality	and	morbidity,	both	medium	and	long‐term	has	yet	to	be	
evaluated.
While	 there	 has	 been	 an	 improvement	 in	 life	 expectancy	
within	the	general	population,	 it	has	been	associated	with	more	
years	living	with	poor	health	or	disability	at	the	end	of	life	(Bell	&	
Marmot,	2017).	This	has	subsequently	 increased	the	anticipated	
number	of	deaths	that	are	likely	to	need	palliative	and	end	of	life	
care	 (Etkind	et	 al.,	 2017).	 There	 appears	 to	be	only	 fragmented	
evidence	relating	to	 (a)	 the	extent	and	nature	of	 the	care	needs	
by	 people	 using	 substances	 and	 (b)	 the	 challenges	 services	will	
face	in	supporting	people	with	problematic	substance	use	at	the	
end	of	 life.	This	Rapid	Evidence	Assessment	 (REA)	aimed	 to	ex‐
plore	what	is	already	known	about	responses	to	end	of	 life	care	
need	for	people	using	substance	and	identify	gaps	in	the	evidence	
base.	It	forms	one	part	of	a	wider	programme	of	research	on	end	
of	 life	care	 for	people	with	problematic	 substance	use	 (Galvani,	
Tetley,	et	al.,	2016).
1.1 | Conceptual framework
Within	 the	 current	 literature,	 discrete	 definitions	 of	 palliative	 as	
opposed	 to	 end	 of	 life	 care	 are	 ambiguous	 and	 indistinct	with	 au‐
thors	often	interchanging	between	the	two	terms.	For	this	REA,	we	
explored	 the	 existing	 theoretical	 literature	 and	 sought	 advice	 from	
experts	 in	 the	 field.	We	based	 the	definition	of	palliative care on a 
combination	 of	 World	 Health	 Organisation	 (WHO)	 guidelines	 and	
part	 of	 a	 definition	 used	 by	 the	 European	Association	 of	 Palliative	
Care	(EAPC):
What is known about this topic
•	 There	 is	an	 increase	 in	older	 substance	users	who	will	
require	end	of	life	care.
•	 Meeting	end	of	 life	needs	for	this	group	of	people	will	
require	flexible	service	provision.
•	 Problematic	 substance	 users	 often	 present	 with	 com‐
plex	 social	 and	medical	 problems	 that	make	 accessing	
formalised	 end	 of	 life	 care	 services	 more	 difficult	 to	
navigate	than	other	populations.
What this paper adds
•	 This	 paper	 identifies	 and	 documents	 the	 limited	 evi‐
dence	base	that	exists	on	end	of	life	care	for	people	with	
substance	problems.
•	 It	 identifies	gaps	 in	 the	evidence	 relating	 to	 focus	and	
methodology.
•	 It	identifies	examples	of	good	practice	and	highlights	fu‐
ture	directions	for	research
     |  3WITHAM eT Al.
Palliative	 care	 is	 an	 approach	 that	 improves	 the	
quality	 of	 life	 of	 patients	 and	 service	 users	 facing	
the	 problems	 associated	 with	 life‐threatening	 ill‐
ness,	 through	 the	 prevention	 and	 relief	 of	 suffering	
by	means	of	early	identification	and	assessment	and	
treatment	of	pain	and	other	problems,	physical,	psy‐
chosocial	and	spiritual.	It	also	provides	care	to	family	
members,	 friends	and	carers	of	patients	and	service	
users	to	recognise	their	need	for	support	in	their	own	
right	and	as	well	as	to	support	them	to	care	for	their	
relative	or	 loved	one.	Palliative	care	affirms	 life	and	
regards	dying	as	a	normal	process;	it	neither	hastens	
nor	postpones	death.	It	sets	out	to	preserve	the	best	
possible	quality	of	life	until	death.
End of life care	definitions	can	have	limited	clinical	utility	since	
recognising	dying	is	difficult	to	assess	or	predict	with	many	chronic	
conditions.	For	this	REA,	our	end	of	 life	definition	remains	similar	
to	the	palliative	care	definition	but	the	time	scale	is	reduced	to	the	
last	12	months	of	life	(General	Medical	Council,	2010).	For	this	REA	
we	excluded	tobacco	and	caffeine.	Drugs	refers	to	illicit	drugs	and	
the	misuse	 of	 prescription	medication.	 Substance	 use	we	 initially	
defined	 as	 current	 or	 previous	 problematic	 alcohol	 or	 other	 drug	
use	(prescribed	or	illicit)	while	receiving	palliative	or	end	of	life	care.	
However,	the	dearth	of	literature	resulted	in	the	definition	changing	
to	include	any	alcohol	or	drug	use,	rather	than	problematic	use,	ex‐
cept	we	retained	problematic	prescription	drug	use	to	ensure	man‐
ageability	of	the	evidence.
2  | METHODS
2.1 | Aims
The	question	to	be	addressed	was;	what	does	the	existing	interna‐
tional	research	and	wider	literature	tell	us	about	current	responses	
to	end	of	life	care	for	people	with	substance	problems?	The	question	
focussed	 initially	 on	 care	 responses	 and	was	 broken	 down	 further	
into	the	following	aims:
1.	 To	explore	and	document	the	evidence	base	that	already	exists	
on	 responses	 to	 end	 of	 life	 care	 for	 people	 with	 substance	
problems.
2.	 To	identify	gaps	in	the	evidence	relating	to	focus	and	methodology.
3.	 To	identify	examples	of	good	practice	and	to	highlight	future	di‐
rections	for	research.
2.2 | Design
A	Rapid	Evidence	Assessment	 (REA)	methodology	was	 identified	
as	 the	most	appropriate	 research	 tool	 to	use	 to	enable	a	 speedy	
identification	 of	 key	 pieces	 of	 evidence.	 This	 would	 inform	 our	
wider	study	and	provide	a	reference	document	to	underpin	further	
work	on	 this	 topic	 in	 policy	 or	 practice.	REAs	 can	be	defined	 as	
providing.
‘…	a	more	structured	and	rigorous	search	and	quality	assessment	
of	 the	evidence	than	a	 literature	review’	but	one	critique	 is	 that	 it	
has	narrower	parameters	and	is	not	“as	exhaustive	as	a	systematic	
review”	 (Department	 for	 International	Development	 (DFID),	 2017:	
online).	 REAs,	 therefore,	 stem	 from	Systematic	 Review	methodol‐
ogy	that,	historically,	focus	on	interventions	and	their	effectiveness	
using	experimental	or	quasi‐experimental	research	design.	By	con‐
trast,	REAs	are	used	to	gain	an	overview	of	the	prevalence	and	qual‐
ity	 of	 evidence	 focusing	 on	 topic	 areas	 to	 support	 commissioning	
or	programming	decisions	 and	 identifying	evidence	gaps	 requiring	
further	research	 (DFID,	2017:	online).	An	REA	is	conducted	within	
a	shorter	 timeframe	than	a	Systematic	Review	but	 retains	 the	key	
characteristics	of	systematic	review;	transparency,	replicability	and	
comprehensiveness	 (Government	 Social	 Research	 (GSR)	 and	 EPPI	
Centre,	2009;	Galvani	&	Forrester,	2011;	GSR,	2013).
Our	initial	goal	was	establishing	if	there	were	any	interventions	
for	 this	 group.	 As	 the	 review	 proceeded,	 the	 lack	 of	 a	 cohesive	
body	 of	 evidence	 to	 answer	 the	 research	 questions	 indicated	 be‐
came	clear.	Therefore,	a	combination	of	a	REA	and	systematic	map‐
ping	 methodology	 (Clapton,	 Rutter,	 &	 Sharif,	 2009)	 was	 adopted.	
Systematic	maps	aim	to	describe	the	existing	literature	and	gaps	in	
the	 literature,	 in	 a	 broad	 topic	 area	 and	 the	 literature	 quality	 and	
content	can	be	analysed	in	depth	or	more	superficially	as	appropri‐
ate	 to	 individual	projects	 (Clapton	et	 al.,	 2009,	p.	11).	The	 review,	
therefore,	was	conducted	with	the	rigour	of	planning	and	approach	
of	an	REA.	However,	as	a	 result	of	our	experience	conducting	 the	
REA	and	the	diversity	of	the	 literature	found,	 it	also	encompassed	
systematic	mapping	of	the	review's	findings.
2.3 | Search methods
This	REA	was	an	 iterative	 review,	 the	 findings	of	which	 sought	 to	
support	the	wider	programme	of	research	of	which	it	was	part.	To	
ensure	it	did	so,	five	separate	protocols	were	developed	for	the	ini‐
tial	 searches	 that	 spoke	directly	 to	 the	 focus	of	 the	other	 strands	
of	the	research.	The	first	protocol	examined	the	prevalence and in‐
cidence	of	palliative/end	of	life	care	and	co‐existing	substance	use/
problematic	 substance	 use.	 The	 second	 reviewed	 interventions	 for	
people	using	alcohol	or	other	drugs	with	co‐existing	end	of	life	con‐
ditions	 and	 their	 families,	 carers,	 friends.	 The	 third	 examined	 the	
personal/family/social experiences,	challenges	and	opportunities,	 for	
people	using	alcohol	or	other	drugs	with	co‐existing	end	of	life	care	
conditions.	 The	 fourth	 and	 fifth	 searches	 focused	 on	 both	profes‐
sional/clinical/practice challenges/concerns	for	practitioners	support‐
ing	 those	using	alcohol	or	other	drugs	with	co‐existing	end	of	 life	
TA B L E  1  Final	search	terms
Key	search	
terms:
End	of	life,	palliative,	dying,	death,	life	limiting,	life	
threatening 
Drug	misuse/abuse/use,	substance	use/misuse/
abuse,	medication	use	or	abuse,	alcohol
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care	conditions	and	good practice models	and	care	pathways	in	rela‐
tion	to	this	population.
These	original	protocols	for	the	review	were	adapted	as	the	REA	
proceeded	due	to	the	very	 limited	relevant	data	generated	by	them.	
This	strategy	allowed	us	to	refine	the	questions	and	the	focus	of	the	
research	 once	 the	 review	was	 being	 conducted.	 Subsequently,	 the	
search	terms	were	broadened	to	capture	all	the	literature	within	this	
field	within	our	search	parameters	(see	Table	1	below).
This	strategy	is	one	of	the	features	of	an	iterative,	as	opposed	to	an	
a	priori,	review.	Two	broad	groups	of	evidence	were	relevant;	existing	
research	 on	 palliative	 and	 end	 of	 life	 care	 and	 existing	 research	 on	
substance	use.	The	search	protocol	needed	to	ensure	these	bodies	of	
evidence	were	included.	Common	to	all	five	searches,	were	the	data‐
bases;	Amed,	Psycharticles,	Ovid,	Ageinfo,	Medline,	Ebscohost,	ASSIA,	
Social	 Care	 Online,	 Web	 of	 Knowledge	 (including	 Social	 Science	
Citations	Index),	Web	of	Science,	SSCI,	Samsha,	NIAAA.
Studies	reviewed	were	published	in	peer‐reviewed	journals	be‐
tween	 1	 January	 2004	 and	 1	 August	 2016.	 The	 rationale	 for	 the	
starting	date	parameter	of	2004	was	the	publication	of	key	reports	
concerning	end	of	life	and	palliative	care	that	year	(Department	of	
Health,	2004;	National	 Institute	 for	Clinical	Excellence,	2004).	An	
additional	 limiter	was	 that	 the	papers	were	written	 in	English.	We	
excluded	tobacco‐related	studies.	Excluded	papers	were	coded	A‐E	
(see	coding	table	below	in	Table	2).
2.4 | Data extraction and synthesis
Given	 the	 dearth	 of	 intervention	 studies	 and	 the	 limited	 literature	
found	 through	 the	 initial	 searching,	 a	 systematic	mapping	 approach	
was	adopted.	This	facilitates	a	visual	map	of	the	existing	literature	on	
the	broad	topic	of	substance	use	and	end	of	life	care.	It	also	allowed	
categorisation	of	 the	existing	evidence	 in	a	number	of	ways,	 includ‐
ing	 its	 methodology,	 focus	 and	 country	 of	 origin.	 Textual	 narrative	
synthesis	 (Barnett‐Page	 &	Thomas,	 2009)	was	 used	 to	 explore	 any	
similarities,	differences	and	relationships	between	papers.	The	textual	
narrative	approach	involves	a	commentary	describing	study	character‐
istics,	context,	quality	and	findings.	This	was	facilitated	by	a	three‐step	
process	(Lucas,	Baird,	Arai,	Law,	&	Roberts,	2007)	including,	(a)	study	
grouping;	in	which	studies	belonging	to	each	of	the	sub‐groups,	for	ex‐
ample	pain	management	or	alcohol	were	identified	with	two	research‐
ers	 independently	 categorising	 and	 theming	 the	 papers.	 (b)	Themes	
produced	by	each	researcher	were	compared	and	a	consolidated	list	
produced.	(c)	sub‐group	synthesis	were	then	developed.	If	there	were	
any	disagreement,	a	 third	 researcher	would	 review	the	paper.	Study	
commentaries	were	produced	in	an	excel	file	to	summarise	key	aspects	
of	the	papers	in	relation	to	the	sub‐group	within	which	they	were	in‐
cluded.	This	included	both	key	findings	and/or	recommendations	that	
speak	to	the	aims	of	this	REA.	In	terms	of	quality	control,	each	com‐
mentary	was	reviewed	by	a	second	researcher	independently	to	assess	
the	summary	in	relation	to	the	original	paper.
2.5 | Quality appraisal
The	 quality	 of	 the	 individual	 studies	was	 assessed	 based	 on	 six	
principles	derived	from	DFID	guidance,	each	of	which	have	a	num‐
ber	of	quality	related	questions	within	the	principles	(DFID,	2014).	
The	key	principles	 are:	 (a)	Conceptual	 framing,	 (b)	Transparency,	
(c)	 Appropriateness,	 (d)	 Cultural	 sensitivity,	 (e)	 Validity	 and	 (f)	
Cogency.
The	empirical	studies	in	the	evidence	base	were	scored	on	all	six	
criteria	on	a	three‐point	scale	reflecting	the	extent	to	which	the	stud‐
ies	followed	good	research	practice:	3	=	no	concerns;	2	=	some	minor	
concerns;	1	=	major	concerns.	This	resulted	in	a	score	ranging	from	6	
to	18	for	each	study.	Studies	were	then	assigned	a	quality	category	
of	high,	moderate	or	low,	based	on	their	score.	It	is	important	to	note	
that	a	low	or	moderate	“quality”	rating	does	not	imply	that	a	study	was	
poorly	designed	or	executed	and	does	not	suggest	that	its	conclusions	
are	incorrect	or	unreliable.	It	can	simply	mean	that	the	report	of	the	
study	did	not	fully	explain	its	design	or	methods.
3  | FINDINGS
The	initial	search	of	peer‐reviewed	articles	resulted	in	a	large	num‐
ber	of	papers.	The	 inclusion	and	exclusion	criteria	were	applied	at	
abstract	and	full	text	reading	stages	(see	Figure	1	below).
There	were	60	papers	generated	from	our	search	after	applying	
the	inclusion	and	exclusion	criteria.	They	were,	however,	extremely	
diverse	 in	methodology,	 focus	 and	 audience.	 The	 systematic	map	
(Figure	 2)	 illustrates	 the	 range	 of	 evidence	 found	 among	 the	 60	
papers.
All	empirical	studies	(n	=	32)	referred	to	in	this	REA	were	scored	
according	to	the	DFID	(2014)	guidance	(Table	3).	Table	3	summarises	
the	evidence	base	found	for	this	REA	in	terms	of	types	of	study	and	
quality.
The	majority	of	papers	found	were	published	in	the	last	decade	
and	were	North	American	(USA	or	Canadian)	in	origin.	Just	over	half	
were	based	on	empirical	 research	of	some	kind	with	more	quanti‐
tative	data	than	qualitative	data	presented.	The	greater	number	of	
journal	articles	compared	to	other	sources	was	a	result	of	our	search	
strategy	which	focussed	on	published	research.	As	with	other	new	
areas	of	research,	for	example	sight	loss	and	substance	use	(Galvani,	
Livingston,	&	Morgan,	2016),	 there	were	a	number	of	clinical	case	
studies	presented	in	the	literature.	The	final	list	of	papers	is	included	
at	the	end	of	this	paper	in	Table	4.
TA B L E  2  Coding	table
A Is	not	related	to	palliative	or	end	of	life	care
B Is	not	related	to	substance	use
C Is	not	related	to	palliative	or	end	of	life	care	or	substance	
use
D Not	about:	practice	or	pathways:	professional	practice	
concerns;	family	and	social	networks
E Does	not	meet	the	above,	but	is	of	interest	and	relevance	
(set	aside).
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3.1 | Thematic groups
As	the	systematic	map	shows,	the	topic	focus	of	the	evidence	could	
be	grouped	around	three	main	themes:	pain	management	(n	=	25),	
homeless	and	miscellaneous	populations	(n	=	24)	and	alcohol‐related	
papers	 (n	 =	 6).	 In	 addition,	 five	 remaining	 papers	were	 diverse	 in	
focus	and	methodology.
3.2 | Pain management
Pain	management	 was,	 marginally,	 the	 largest	 category	 to	 emerge	
from	the	peer‐reviewed	 literature.	The	majority	 (n	=	23)	were	from	
the	USA	with	the	other	single	papers	from	Canada	and	the	UK.	The	
studies	ranged	from	clinical	chart/note	reviews	(Barclays	et	al.,	2014;	
Childers	et	al.,	2015;	Kwon	et	al.,	2013,	2015;	Rowley	et	al.,	2011),	to	
small	scale	case	study	reviews	(Arthur	et	al.,	2016;	Burton‐MacLeod	
et	al.,	2008;	Farnham,	2012;	Kirsh	&	Passik,	2006;	Koyyalagunta	et	
al.,	2011;	Kutzen,	2004;	Walsh	&	Broglio,	2010).	There	was	also	one	
integrated	 literature	 review	 (Carmichael	 et	 al.,	 2016)	examining	as‐
sessment	and	risk	in	relation	to	opioid	misuse	within	cancer	care	and	
two	systematic	reviews	(Chou	et	al.,	2009;	Taveros	&	Chuang,	2016).	
Chou	et	al.	(2009)	examined	opioid	misuse	in	the	context	on	non‐can‐
cer	chronic	pain	and	Taveros	and	Chuang	(2016)	examined	pain	man‐
agement	strategies	for	people	on	methadone	maintenance	therapy.	
Five	studies	used	structured	questionnaires	as	part	of	their	approach	
(Blackhall	et	al.,	2013;	Childers	&	Arnold,	2012;	Knowlton	et	al.,	2015;	
Williams	et	al.,	2014;	Tan	et	al.,	2014).	The	remaining	five	papers	were	
descriptions	 or	 discussions	 of	 practice	 (Krashin	 et	 al.,	 2012,	 2015;	
Passik	et	al.,	2009;	Pancari	&	Baird,	2014;	Riesfield	et	al.,	2009).
In	 terms	 of	 the	 populations	 of	 interest,	 the	 majority	 of	 pa‐
pers	(n	=	13)	were	within	a	context	of	pain	in	cancer	care	(Arthur	
et	 al.,	 2016;	 Barclay	 et	 al.,	 2014,	 Burton‐MacLeod	 et	 al.,	 2008;	
Carmichael	 et	 al.	 2016;	 Childers	 et	 al.,	 2015;	 Kirsh	 &	 Passik,	
2006;	Koyyalagunta	et	al.,	2011;	Kwon	et	al.,	2013,	2015;	Passik	
et	al.,	2009;	Rowley	et	al.,	2011;	Taveros	&	Chuang,	2016;	Walsh	
&	 Broglio,	 2010).	 One	 study	 examined	 pain	 in	 prison	 popula‐
tions	 (Williams	 et	 al.,	 2014)	whilst	 Kutzen	 (2004)	 and	Knowlton	
et	 al.	 (2015)	 focused	on	pain	 in	 the	context	of	HIV	disease	with	
Koyyalagunta	et	al.	(2011)	also	exploring	a	subset	of	HIV	patients.	
The	 other	 studies	 examined	 problematic	 substance	 use	 from	 a	
general	palliative	care	context	(Childers	&	Arnold,	2012,	Farnham,	
2012;	Krashin	et	al.,	2015;	Pancari	&	Baird,	2014,	Riesfield	et	al.,	
2009;	Tan	et	al.,	2014)	with	two	studies	focussing	on	chronic	non‐
cancer	pain	(Chou	et	al.,	2009;	Krashin	et	al.,	2012).	A	number	of	
papers	 acknowledged	 both	 the	 complexity	 of	 pain	management	
and	 persistent	 issues	 of	 under‐treatment	 of	 patients	 with	 sub‐
stance	misuse	 issues	 (Farnham,	2012;	Koyyalagunta	et	al.,	2011;	
Krashin	et	al.,	2015;	Kwon	et	al.,	2015;	Lum,	2003;	Passik	et	al.,	
2009;	Rowley	et	al.,	2011;	Walsh	&	Broglio,	2010;	Williams	et	al.,	
2014).	 This	 led	most	 papers	 to	 emphasise	 the	need	 for	 compre‐
hensive	assessment	as	an	essential	step	in	managing	pain	in	people	
using	substances,	requiring	active	engagement	from	the	clinician.
F I G U R E  1  Review	process	from	initial	
search	to	final	sample	of	papers Total number of hits
n = 4384
First screening of tles 
Total removed
n = 4232
Second screening of 
abstracts
Total removed
n = 82
Not about sub use n = 25
Not about EOL care n = 36
Neither about sub use or EOL  n = 21
Full text reading
Total removed
n = 10
Not about sub use n = 6
Not about EOL care n = 2
Neither about sub use or EOL n = 2
Final sample for inclusion
n = 60
Not about sub use or EOL  
n = 4232
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3.3 | Homeless and marginalised groups
This	group	of	papers	focussed	on	people	who	are	homeless	or	pre‐
cariously	housed,	people	with	mental	health	difficulties	and	people	
with	HIV	 in	 the	context	of	multiple	 social	problems.	Three	papers	
addressed	marginalised	populations	more	generally	(Doukas,	2014;	
Dzul‐Church	et	al.,	2010;	Sulistio	&	Jackson,	2013).
3.4 | Homeless populations
The	 majority	 of	 papers	 in	 this	 thematic	 group	 focussed	 on	 home‐
less	and	precariously	housed	persons	 (Collier,	2011;	Dzul‐Church	et	
al.,	2010,	Hudson,	2016;	Kusel	&	Miaskowski,	2006;	MacWilliams	et	
al.,	 2014;	McNeil	&	Guirguis‐Younger,	 2012a,	 2012b;	McNeil	 et	 al.,	
2012a;	McNeil	et	al.,	2012b;	Page	et	al.,	2012;	Podymow	et	al.,	2006;	
Song	et	al.,	2007a,	2007b).	Most	were	qualitative	studies	conducted	in	
Canada	(n	=	7),	with	four	from	the	USA	and	one	from	Australia	and	two	
from	the	UK.	The	four	papers	by	McNeil	and	colleagues	drew	on	a	sin‐
gle	primary	piece	of	qualitative	work	to	examine	the	particular	needs	
of	homeless	people,	including	staff	experiences.	The	research	looked	
at	gaps	in	services	and	proposed	that	some	of	these	could	be	met	by	
“shelter‐based”	palliative	and	end	of	life	care.	The	work	of	Song	et	al.	
(2007a,	 2007b)	 and	 Podymow	et	 al.	 (2006)	 identified	 similar	 issues	
finding	that	end	of	life	advanced	directives	were	perceived	very	posi‐
tively	by	homeless	people	including	“do	not	attempt	cardio‐pulmonary	
resuscitation”	orders.	As	Song	et	al	(2007a)	comment,	participants	ex‐
pressed	preferences	to	avoid	“heroic	interventions”,	with	advance	care	
planning	being	 important	because	of	 their	 ‘…	belief	 that	EOL	care	 is	
paternalistic	and	unresponsive,	advance	care	planning	was	also	seen	
as	a	way	to	maintain	control’	(p.	437).
F I G U R E  2  Systematic	map:	Substance	
use	and	end	of	life	care
Date: (n = 60) 
(date parameters 2004-2016)
2004-2008 (n = 12) 20%
2009- 2012 (n = 23)  38.3%
2013-2016  (n = 25) 41.6%
Country (n = 60)
USA   (n = 34) 56.7% 
Canada (n = 12) 20%
UK   (n = 9)  15%
Australia   (n = 3)  5%
Italy  (n = 1)  1.6%
Sweden (n = 1) 1.6%
Type of Publication (n = 60)
Journal Article   (n = 58)  96.7%
Book chapter  (n = 2)  3.2%
Content (n = 60)
Pain management (n = 25)  41.6 %
Homelessness and marginalised 
groups  (n =24 ) 40%
Alcohol related  (n = 6 )  10%
Other (n = 5) 8.3%
Empirical/Unempirical (n = 60)
Empirical  (n = 32) 53.3 %
Unempirical  (n = 28)  46.6%
Qualitative/Quantitative/Mixed 
Methods (n = 32)
Qualitative  (n = 11)  34.3%
Quantitative  (n = 21) 65.6% 
Mixed  (n = 0) 
Type of Study (n = 32)
EMPIRICAL
Cross sectional  (n = 6)  18.7%
Focus groups  (n = 2)  6.2%
Interview  (n = 9)  28.1%
Survey (n =6) 18.7%
Retrospective Chart review (RCR) (n = 
9) 28.1%
Type of Study (cont.)
UNEMPIRICAL (n= 28)
Case study  (n =10)  35.7%
Description of practice  (n =8)  28.5%
Literature review  (n = 5) 17.8%
Systematic review (n=3) 10.7%
Book chapter (n=2) 7.1%
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MacWilliams	et	al.’s	(2014)	case	study	approach	identified	sim‐
ilar	 issues	 but	 focused	on	 the	 consequent	 difficulties	with	 com‐
pliance	 in	treatment.	 In	particular,	 they	discussed	what	this	then	
meant	for	pain	control	and	reducing	the	risks	of	sudden	crisis	and	
deterioration	where	someone	is	homeless.	Kushel	and	Miaskowski	
(2006)	identified	the	usefulness	of	“patient	contracts”	as	a	means	
of	 addressing	 such	 difficulties.	 The	 remaining	 papers	 examining	
homelessness	 included	 one	 systematic	 review	 paper	 from	 the	
UK,	(Hudson,	2016),	Webb	(2005)	who	examined	seven	UK	hostel	
workers’	 experiences	 in	 relation	 to	 supporting	 homeless	 people	
at	their	end	of	life,	and	a	paper	by	Page	et	al.	(2012)	which	looked	
at	causes	of	death	among	homeless	people	 in	Alberta.	The	 find‐
ings	from	this	study	showed	that	most	deaths	were	due	to	“natural	
causes”;	that	is,	not	the	types	of	death	often	associated	with	drug	
use	 such	 as	 overdoses	 and	 suicides.	 Page	 et	 al.	 (2012)	 also	 pro‐
posed	 that	 this	meant	 that	 the	 circumstances	of	 death	 could	be	
improved	by	more	effective	delivery	of	end	of	life	care	to	home‐
less	persons.
3.5 | Mental Health, HIV and miscellaneous groups
Mental	ill	health	was	highlighted	in	many	of	the	papers	identified	
in	this	review.	Depression	is	known	to	be	associated	with	chronic	
and	terminal	illness	and	with	pain,	both	as	a	factor	in	causation	and	
arising	as	a	consequence	of	 illness	 (Hotopf,	Chidgey,	Addington‐
Hall,	&	Lan	Ly,	2002).	This	 links	with	the	pain	 literature,	where	a	
number	 of	 authors	 suggested	 screening	 and	 referral	 to	 second‐
ary	 mental	 health	 services	 as	 an	 appropriate	 response	 (Barclay	
et	al.,	2014;	Burton‐MacLeod	et	al.,	2008;	Kirsh	&	Passik,	2006;	
Koyyalagunta	et	al.,	2011;	Krashin	et	al.,	2015).	Mental	 ill	health	
was	identified	as	a	primary	issue	in	a	review	paper	by	Miovic	and	
Block	(2007)	looking	at	psychiatric	disorders	and	substance	“mis‐
use”	in	advanced	cancer.	Antoni	et	al.	(2012)	examined	substance	
“misuse”	experienced	by	US	army	veterans.	Halman	et	al.	 (2014)	
undertook	 a	 retrospective	 chart	 review	 (single	 institution)	 from	
83	 late‐stage	 HIV	 patients	 from	 Canada	 highlighting	 substance	
use	 co‐morbidities	 of	 a	 subset	of	 people	dying	with	HIV‐related	
conditions.	 Two	 papers	 from	 the	 USA,	 Karus	 et	 al.	 (2004)	 and	
Morgan	and	Kochan	(2008)	explored	HIV	in	relation	to	substance	
use	 and	 end	 of	 life	 and	 found	 issues	 of	 underlying	 poverty	 and	
a	 lack	of	sufficient	health	 insurance.	HIV	disease	per	se	was	not	
seen	as	an	issue	for	end	of	life	care	but	rather	HIV	in	a	cluster	of	
mental	health	problems	alongside	substance	use,	the	combination	
of	which	raises	the	sorts	of	 issues	previously	highlighted	around	
compliance	and	pain	control.	There	were	 four	papers	addressing	
what	we	have	termed	marginalised	populations	including	a	discus‐
sion	paper,	proposing	that	training	was	needed	to	increase	meth‐
adone	 counsellors’	 palliative	 and	 end	 of	 life	 care	 skills	 (Doukas,	
2014).	 This	 was	 echoed	 by	 Mundt‐Leach	 (2016)	 who	 suggests	
closer	 working	 relationships	 between	 palliative	 care	 and	 addic‐
tion	services.	Dzul‐Church	et	al.	 (2010)	and	Sulistio	and	Jackson	
(2013)	highlight	complex	 issues	 related	 to	poverty,	multiple	sub‐
stance	use	and	emotional	and	social	difficulties.	In	particular,	pain	
management	 strategies	 should	be	more	effective	with	 increased	
awareness	of	the	challenges	in	prescribing	for	analgesia	compared	
with	 opioid	 substitution	 therapy	 (Sulistio	 &	 Jackson,	 2013)	 and	
healthcare	providers	 should	examine	 the	complexity	of	needs	 in	
these	 populations	 and	 provide	 structured,	 person‐centred	 ap‐
proaches	predicated	on	effective	communication.
3.6 | Alcohol
There	were	six	papers	identified	that	had	alcohol	as	a	primary	focus	
(Dev	et	al.,	2011;	Irwin	et	al.,	2005;	Kwon	et	al.,	2013b;	Mercadante	
et	al.,	2015;	Poonja	et	al.,	2014;	Webber	&	Davies,	2012).	Five	of	the	
papers	examined	alcohol	use	in	relation	to	cancer	and	one	related	to	
liver	cirrhosis.	Men	form	the	overwhelming	majority	of	problematic	
alcohol	users;	usually	by	a	factor	of	more	than	2:1	and	this	contin‐
ues	into	the	palliative/advanced	cancer	population.	This	gender	bias	
was	reflected	in	the	populations	of	the	existing	evidence	on	alcohol	
and	end	of	 life	care.	However,	problematic	alcohol	use	appears	 to	
be	more	common	in	younger	palliative	populations	referred	late	to	
supportive	 palliative	 care	 services	 (Kwon	et	 al.,	 2013b).	The	most	
frequently	 used	 alcohol	 screening	 instrument	 documented	 in	 the	
evidence	to	date	appears	to	be	the	CAGE	questionnaire	(Dev	et	al.,	
2011;	Kwon	et	al.,	2013,	2015;	Mercadante	et	al.,	2015)	although	
others	are	used	in	addition	to	or	 instead	of,	CAGE.	The	papers	fo‐
cussed	 on	 the	 importance	 of	 screening	 and	 concerns	 about	 “un‐
documented”	alcohol	difficulties	and	its	 impact	on	people's	end	of	
life	experience.	This	focus	on	screening	for	alcohol	problems	among	
the	 end	 of	 life	 care	 population	mirrors	 the	 concerns	 identified	 in	
the	pain	literature	around	“chemical	coping”,	where	people	use	sub‐
stances	 to	 compensate	 for	 the	 inadequate	 pain	 relief	 prescribed	
(Kwon	et	al.,	2015).
Study quality Symbol Type of study Number % of all studies
High	(14–18) ↑ Primary 
Secondary
9 28.1%
Moderate	(10–13) → Primary 
Secondary
18 56.2%
Low	(6–9) ↓ Primary 
Secondary
5 15.6%
Total   32 100%
TA B L E  3  Quality	ratings	of	empirical	
literature
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TA B L E  4  Final	included	papers
FINAL PAPERS (n = 60) Quality indicator Country of Origin
Antoni,	C.,	Silverman,	M.	A.,	Nasr,	S.	Z.,	Mandi,	D.	&	Golden,	A.	G.	(2012).	Providing	support	through	
life's	final	chapter	for	those	who	made	it	home.	Military Medicine,	177(12),	1498–1501.	https	://doi.
org/10.7205/MILMED‐D‐12‐00315	
Non‐empirical USA
Arthur,	J.	A.,	Haider,	A.,	Edwards,	T.,	Waletich‐Flemming,	J.,	Reddy,	S.,	Bruera,	E.,	&	Hui,	D.	(2016).	
Aberrant	opioid	use	and	urine	drug	testing	in	outpatient	palliative	care.	Journal of Palliative Medicine,	
19(7),	778–782.	https	://doi.org/10.1089/jpm.2015.0335
Non‐empirical USA
Barclay,	J.	S.,	Owens,	J.	E.,	&	Blackhall,	L.	J.	(2014).	Screening	for	substance	abuse	risk	in	cancer	pa‐
tients	using	the	Opioid	Risk	Tool	and	urine	drug	screen.	Supportive Care In Cancer,	22(7),	1883–1888.	
https	://doi.org/10.1007/s00520‐014‐2167‐6
15 USA
Beynon,	C.,	McVeigh,	J.,	Hurst,	A.,	&	Marr,	A.	(2010a).	Older	and	sicker:	Changing	mortality	of	drug	
users	in	treatment	in	the	North	West	of	England.	International Journal of Drug Policy,	21(5),	429–431.	
DOI:	10.1016/j.drugpo.2010.01.012
9 UK
Beynon,	C.,	Stimson,	G.,	&	Lawson,	E.	(2010b).	Illegal	drug	use	in	the	age	of	ageing.	British Journal of 
General Practice,	60	(576),	481–482.	DOI:	10.3399/bjgp1	0X514710
Non‐empirical UK
Blackhall,	L.	J.,	Alfson,	E.	D.,	&	Barclay,	J.	S.	(2013).	Screening	for	substance	abuse	and	diversion	in	vir‐
ginia	hospices. Journal of Palliative Medicine,	16	(3),	237–242.	https	://doi.org/10.1089/jpm.2012.0263
8 USA
Burton‐MacLeod,	S.,	&	Fainsinger,	R.,	L.	(2008).	Cancer	pain	control	in	the	setting	of	substance	use:	
Establishing	goals	of	care.	Journal of Palliative Care,	24	(2),	122–125.
Non‐empirical Canada
Carmichael,	A.,	N.,	Morgan,	L.,	&	Del	Fabbro,	E.	(2016).	Identifying	and	assessing	the	risk	of	opioid	
abuse	in	patients	with	cancer:	an	integrative	review.	Substance Abuse And Rehabilitation,	7,	71–79.	
https	://doi.org/10.2147/SAR.S85409
Non‐empirical USA
Childers,	J.	W.,	&	Arnold,	R.	M.	(2012).	"I	feel	uncomfortable	'calling	a	patient	out”:	Educational	needs	
of	palliative	medicine	fellows	in	managing	opioid	misuse.	Journal of Pain and Symptom Management,	
43(2),	253–260.	DOI:	10.1016/j.jpain	symman.2011.03.009
12 USA
Childers,	J.	W.,	King,	L.	A.,	&	Arnold,	R.	M.	(2015).	Chronic	pain	and	risk	factors	for	opioid	misuse	in	
a	palliative	care	clinic.	American Journal of Hospice & Palliative Medicine,	32(6),	654–659.	https	://doi.
org/10.1177/10499	09114	531445
14 USA
Chou,	R.,	Fanciullo,	G.	J.,	Fine,	P.	G.,	Passik,	S.	D.,	&	Portenoy,	R.	K.	(2009).	Opioids	for	chronic	noncan‐
cer	pain:	prediction	and	identification	of	aberrant	drug‐related	behaviors:	A	review	of	the	evidence	
for	an	American	Pain	Society	and	American	academy	of	pain	medicine	clinical	practice	guideline.	The 
Journal of Pain,	10(2),	131–146.	https	://doi.org/10.1016/j.jpain.2008.10.009
Non‐empirical USA
Collier,	R.	(2011).	Bringing	palliative	care	to	the	homeless.	CMAJ:	Canadian Medical Association Journal,	
183(6),	E317‐E318.	https	://doi.org/10.1503/cmaj.109–3756
Non‐empirical Canada
Corkery,	J.	(2008).	UK	drug‐related	mortality	‐‐	issues	in	definition	and	classification.	Drugs & Alcohol 
Today,	8(2),	17–25.	https	://doi.org/10.1108/17459	26520	0800014
Non‐empirical UK
Dev,	R.,	Parsons,	H.	A.,	Palla,	S.,	Palmer,	J.	L.,	Del	Fabbro,	E.,	&	Bruera,	E.	(2011).	Undocumented	
alcoholism	and	its	correlation	with	tobacco	and	illegal	drug	use	in	advanced	cancer	patients.	Cancer,	
117(19),	4551–4556.	DOI:	10.1002/cncr.26082	
11 USA
Doukas,	N.	(2014).	Are	methadone	counselors	properly	equipped	to	meet	the	palliative	care	needs	of	
older	adults	in	methadone	maintenance	treatment?	Implications	for	Training.	Journal of Social Work in 
End‐ of‐ Life & Palliative Care,	10(2),	186–204.	https	://doi.org/10.1080/15524	256.2014.906370.
Non‐empirical Canada
Dzul‐Church,	V.,	Cimino,	J.	W.,	Adler,	S.	R.,	Wong,	P.	&	Anderson,	W.	G.	(2010).	"I'm	sitting	here	by	
myself...":	experiences	of	patients	with	serious	illness	at	an	Urban	Public	Hospital.	Journal of Palliative 
Medicine,	13(6),	695–701.	https	://doi.org/10.1089/jpm.2009.0352
15 USA
Farnham,	C.	(2012).	Palliative	Care	for	Substance	Misusers.	In	D.	Olivere,	B.,	Monroe,	&	S.	Payne.	(Eds.).	
Death, Dying, and Social Differences	(2nd	Edition)	(pp.	173–182).	Oxford,	Oxford	University	Press.	https	
://doi.org/10.1093/acpro	f:oso/97801	99599	295.001.0001
Non‐empirical UK
Halman,	M.,	Carusone,	S.	C.,	Stranks,	S.,	Schaefer‐McDaniel,	N.	&	Stewart,	A.	(2013).	Complex	care	
needs	of	patients	with	late‐stage	HIV	disease:	A	retrospective	study.	AIDS Care,	26(3),	320–325.	https	
://doi.org/10.1080/09540	121.2013.819404
11 Canada
Hudson,	B.	F.	(2016).	Challenges	to	access	and	provision	of	palliative	care	for	people	who	are	homeless:	
A	systematic	review	of	qualitative	research.	BMC Palliative Care,	15(1),	96.	https	://doi.org/10.1186/
s12904‐016‐0168–6
Non‐empirical UK
(Continues)
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Irwin,	P.,	Murray,	S.,	Bilinski	A.,	Chern,	B.,	&	Stafford,	B.	(2005).	Alcohol	withdrawal	as	an	underrated	
cause	of	agitated	delirium	and	terminal	restlessness	in	patients	with	advanced	malignancy.	Journal of 
Pain & Symptom Management,	29(1),	104–108.	DOI:	10.1016/j.jpain	symman.2004.04.010
Non‐empirical Australia
Karus,	D.,	Raveis,	V.,	Marconi,	K.,	Hanna,	B.,	Selwyn,	P.,	Alexander,	C.,	Perrone,	M.,	&	Higginson,	
I.	(2004).	Service	needs	of	patients	with	advanced	HIV	disease:	a	comparison	of	client	and	staff	
reports	at	three	palliative	care	projects.	Aids Patient Care and STDs,	18(3),	145–158.	https	://doi.
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3.7 | Miscellaneous
There	were	five	papers	that	fell	outside	of	the	thematic	groups	identi‐
fied.	Beynon,	McVeigh,	Hurst,	and	Marr	(2010)	examined	the	changing	
patterns	of	causes	of	death	among	substance	users	in	the	North	West	
of	England.	They	found	that	the	median	age	of	death	rose	from	36.46	in	
2003–2004	to	41.38	in	2007–2008	and	that	causes	of	death	were	in‐
creasingly	related	to	chronic	conditions	more	associated	with	older	age.	
Stenbacka	et	al.	(2010)	reviewed	changes	in	substance‐related	mortal‐
ity	patterns	 in	Sweden	and	 found	that	 the	average	age	of	death	was	
47	years;	25–30	years	 less	 than	 the	general	population.	Women	had	
lower	mortality	rates	and	accidents	and	suicides	were	the	most	common	
causes	of	death	in	younger	substance	users,	with	cardiovascular	disease	
and	 tumours	 most	 common	 among	 older	 substance	 users.	 Corkery	
(2008)	reviewed	classification	issues	in	drug	related	deaths	(DRD)	in	the	
UK	and	found	DRDs	fall	into	two	broad	categories;	those	directly	attrib‐
utable	to	drug	use	(overdoses	and	poisoning)	and	indirectly	attributable,	
that	is,	related	to	drug	use	such	as	infections	and	accidents.	The	author	
suggests	 that	more	attention	 is	given	to	direct	DRDs	rather	 than	the	
long‐term	consequences	of	drug	use.	Two	papers	looked	at	older	drug	
users	 in	particular.	Roe	et	al.	 (2010)	undertook	qualitative	 interviews	
(n	=	11)	with	older	drugs	users	who	used	a	voluntary	drug	treatment	
service	and	found	drug	use	impacts	negatively	on	health	and	family	re‐
lationships	and	support.	Many	older	users	lived	alone	and	had	multiple	
experiences	of	loss.	Beynon	et	al.	(2010b)	reviewed	UK	patterns	of	drug	
use	with	a	focus	on	older	users.	They	found	older	drug	users	presented	
with	specific	challenges,	such	as	interactions	between	legal	and	illegal	
drugs,	 lack	of	social	support,	cognitive	 impairment	and	 issues	around	
managing	pain,	particularly	at	their	end	of	life.
4  | DISCUSSION
There	is	a	lack	of	diversity,	quality,	breadth	and	depth	to	the	litera‐
ture	on	palliative	and	end	of	 life	care	 for	people	with	problematic	
substance	use.	The	gaps	in	the	existing	evidence	are	multiple,	both	
in	terms	of	focus	and	methodology.	However,	this	is	not	surprising	
in	a	newly	recognised	area	of	practice	and	research.	What	is	evident	
is	the	 lack	of	research	on	responses	to	and	 interventions	for,	peo‐
ple	with	problematic	substance	use	and	palliative	or	end	of	life	care	
needs.	 It	 appears	 policy	 and	 practice	 have	 yet	 to	 respond	 to	 the	
emerging	needs	of	people	with	problematic	substance	use	at	or	near,	
their	end	of	life	in	a	significant	way.	This	is	a	concern	given	the	trends	
around	 substance	use	 among	older	 age	groups	 and	 the	 increasing	
longevity	 of	 the	 general	 population.	 This	 absence	 of	 practice	 re‐
sponse	is	reflected	in	the	gaps	in	the	evidence	base	and	can	reflect	
a	lack	of	patient	involvement	in	order	to	drive	through	relevant	and	
effective	health	improvements	that	reflect	the	complexity	and	need	
of	this	population	(Luxford	&	Sutton,	2014).
The	implications	from	this	REA	would	suggest	that	more	empir‐
ical	research	needs	to	be	conducted	exploring	all	aspects	of	prob‐
lematic	substance	use	and	palliative	and	end	of	life	care.	There	is	a	
lack	of	data	from	countries	outside	of	North	America.	Comparative	
studies	would	be	particularly	beneficial	to	our	understanding	of	the	
issues,	 as	would	health	 and	 social	 care	 responses	within	 different	
cultural	contexts.	There	may	be	different	healthcare	professional	re‐
sponses	in	relation	to	palliative	and	end	of	life	care	within	East	Asian	
countries	(Morita	et	al.,	2015),	for	example	or	even	culturally	diverse	
communities	within	western	countries	(Owen	&	Randhawa,	2004).
There	were	few	prevalence	studies	identified.	This	is	an	area	re‐
quiring	more	epidemiological	research	to	provide	a	wider	context	for	
policy	and	practice	development.	In	terms	of	methodological	inquiry,	
more	quantitative	approaches	are	needed	to	provide	larger	scale	data	
on	the	experiences	of	particular	populations	involved	in	service	pro‐
vision,	e.g.	palliative	care	social	workers,	community	nurse	provision.
Further	research	is	needed	on	conditions	other	than	cancer	that	
co‐exist	with	substance	use,	both	in	terms	of	their	prevalence	and	
incidence	 and	 also	 the	 health	 and	 social	 care	 responses	 available	
to	 people	with	 experience	 of	 both	 substance	 use	 and	 life	 limiting	
illness.	 There	 are	 a	 wide	 range	 of	 co‐morbidities	 associated	 with	
substance	 use,	 including	 COPD,	 diabetes,	 cardiovascular	 disease,	
mental	health	problems	and	liver	disease	(Cullen,	O’Brien,	O’Carroll,	
O’Kelly,	&	Bury,	2009;	Shield	et	al.,	2014).
There	was	no	research	 identifying	models	of	good	practice	for	
working	with	co‐existing	substance	use	and	palliative	or	end	of	life	
conditions;	 they	need	developing,	piloting	and	evaluating	 for	 their	
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effectiveness.	Aldridge	et	al.	(2017)	and	Luchenski	et	al.	(2018)	high‐
light	 the	 issues	 related	 to	 marginalised	 and	 excluded	 populations	
and	recommends	 intervention	development	targeting	modification	
of	social	determinants	of	health	like	housing	and	training.	They	also	
recommend	examining	models	of	care	a	primary,	secondary	and	pre‐
ventative	levels	to	assess	need	at	a	population	level.
Qualitative	inquiry	is	required	to	establish	the	needs	of	family	and	
friends	of	people	with	substance	use	problems	at	or	near,	 their	end	
of	life.	Such	qualitative	inquiry	should	extend	to	patients’	voices	that	
are	currently	under‐researched	and	almost	absent	 from	 the	existing	
evidence.	More	dense	description	is	required	including	social,	demo‐
graphic	and	health	profiles	of	participants	as	well	as	setting	and	context	
to	enhance	transferability	(Rolfe,	Ramsden,	Banner,	&	Graham,	2018).	
A	clear	representation	of	people	with	problematic	substance	use	can	
give	diverse	perspectives	to	design	relevant	and	appropriate	studies	
and	enhance	sustainability	(Wilson	et	al.,	2015).	Research	should	also	
include	the	experiences,	views	and	attitudes	of	social	and	healthcare	
professionals	in	responding	to	the	overlapping	issues	of	substance	use	
and	palliative	and	end	of	life	conditions.	This	could	include	concerns	
about	potential	safety	risks	for	outreach	or	community‐based	practice	
in	particular,	as	highlighted	by	Galvani,	Dance,	and	Wright	 (2018)	 in	
their	study	of	hospice	and	specialist	substance	use	staff.	Lastly,	there	
was	limited	evidence	found	in	relation	to	alcohol	(for	example,	prob‐
lematic	alcohol	consumption	associated	with	liver	cirrhosis	specifically	
at	the	end	of	 life).	Further	work	needs	to	be	done	in	this	area	given	
alcohol	remains	the	most	commonly	used	substance.	The	full	REA	re‐
port	for	this	work	can	be	accessed	for	further	 information	 (Witham,	
Galvani,	&	Peacock,	2018).
4.1 | Limitations
REAs	 have	 a	 number	 of	 limitations	 including	 the	 breadth	 and	
depth	of	 the	searching.	The	number	and	type	of	databases	used	
for	 searching	 are	 often	 limited	 to	 allow	 for	 a	 more	 rapid	 result	
and	usually	do	not	include	the	comprehensive	searching	involved	
in	 systematic	 reviews	 (,	undated).	These	 limitations	apply	 to	 this	
study	 too.	 The	 decision	 to	 set	 the	 cut‐off	 date	 at	 2004	 and	 to	
access	 only	 English	 language	 literature	meant	 that	 some	 studies	
may	have	been	missed	and	 it	 is	not	possible	 to	know	how	many	
would	have	met	our	inclusion	criteria.	Nevertheless,	agreeing	and	
adhering	to	a	date	limiter	is	an	accepted	feature	of	REA’s	as	is	the	
need	to	set	limits	on	the	retrieval	of	full	texts	(Government	Social	
Research	&	EPPI	Centres,	2009).	Thirteen	databases	across	health	
and	 social	 care	 sources	were	 accessed	 for	 this	 review.	 It	 is	 pos‐
sible	that	more	databases	may	have	produced	additional	material.	
Similarly,	 expanding	 our	 search	 terms	 to	 include	 specific	 health	
conditions	 and	 specific	 types	 of	 licit	 and	 illicit	 drugs	 may	 have	
produced	 further	hits.	Data	extraction	 and	 critique	 is	often	 lim‐
ited	with	REAs	resulting	in	a	focus	on	methodology	and	only	key	
elements	 of	 data.	While	 this	 review	went	 slighter	 deeper	 in	 our	
reading	and	grouping	of	content	within	the	evidence,	a	less	rapid	
review	could	have	included	this	greater	depth.
5  | CONCLUSION
This	REA	set	out	to	explore	current	responses	to	and	models	of	prac‐
tice	for,	people	living	with	problematic	substance	use	and	palliative	and	
end	of	life	care	conditions.	There	is	a	dearth	of	research	available	on	
this	 topic	and	 thus	 the	 focus	of	 this	 review	was	broadened	 to	 iden‐
tify	what	evidence	was	available,	its	focus,	quality	and	the	gaps	in	the	
research	evidence	base.	The	resulting	body	of	work	comprised	60	pa‐
pers,	primarily	from	peer‐reviewed	journals.	 It	was	quite	disparate	 in	
focus,	with	a	diverse	range	of	research	populations,	research	questions	
and	methodological	 choices.	The	 available	 evidence	 resulted	 in	 two	
clear,	but	limited,	groups	of	papers,	those	focussing	on	pain	manage‐
ment	and	prescribing	and	those	focussing	on	homelessness,	substance	
use	and	end	of	life	care.	A	third	group	included	a	small	body	of	work	
on	alcohol	and	palliative	or	end	of	life	care	and	a	small	number	of	other	
papers	including	co‐existing	mental	health	or	HIV‐related	conditions.	
This	is	clearly	an	area	of	work	where	far	more	research	is	needed.	It	is	a	
new	area	of	work	and	research	focus	and	that	has	to	be	considered	in	
considering	our	findings.	However,	the	gaps	identified	are	considerable	
and	need	to	be	filled	in	order	to	provide	an	evidence	base	on	which	to	
build	future	good	policy	and	practice,	both	in	the	UK	and	internation‐
ally.	Ultimately,	this	work	is	needed	to	ensure	that	this	growing	group	
of	people	have	good	quality	care	and	equal	access	to	service	provision.
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